Oral Probiotics for Halitosis in Healthy Adults
ConditionHalitosis
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorJohn Hale
About this trial
The aim of this study is to evaluate efficacy of a probiotic lozenge containing BLIS M18, BLIS K12 and a prebiotic in healthy adults.
Eligibility criteria
Qualifiers
Participants should be otherwise healthy,
practice good oral hygiene,
18 - 70 years of age
Disqualifiers
on antibiotic therapy,
immunocompromised (have a weakened immune system)
history of autoimmune disease,
allergy or sensitivity to dairy,
Trial design
Treatments tested in this trial
- In this study, a probiotic lozenge formulation containing S. salivarius K12, M18 and prebiotic will be evaluated for its potential to improve bad breath
- Placebo
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
John Hale
Lead sponsor
BLIS Technologies Limited
Sponsor institution
Source ClinicalTrials.gov